REBIRTH Colloquium

For many years the Research Center for Translational Regenerative Medicine REBIRTH (“From Regenerative Biology to Reconstructive Therapy”) has promoted the scientific exchange in the field of regenerative therapies through regular lecture events.

The REBIRTH colloquium usually takes place every month, Wednesday at 1 pm. Additionally, special lectures of invited external lecturers take place within the scope of the colloquium.

The colloquium serves as a discussion forum of 'REBIRTH' and is not only supposed to promote the initiation of external cooperations, but rather internal (and interdisciplinary) cooperations. Therefore, in addition to external lecturers, both REBIRTH members and scientists of related research fields present current data and projects.


22.02.2023 REBIRTH colloquium (1 pm s.t., online lecture)

‘Genetic engineering of organs to support graft survival after transplantation’ 
Prof. Dr. Constanca Figueiredo, Institute of Transfusion Medicine and Transplant Engineering, MHH

‘Of drugs and tools - novel concepts for pharmaceutical research ‘
Prof. Dr. Oliver Plettenburg, Medicinal Chemistry at Leibniz University Hannover (and Institute for Medicinal Chemistry, Helmholtz Munich)


18.05.2022 REBIRTH colloquium (1 pm s.t., online lecture)

‘Role of c-myc in chronic liver diseases’
Prof. Dr. Arndt Vogel, Department of Gastroenterology, Hepatology & Endocrinology, MHH


16.03.2022 REBIRTH colloquium (1 pm s.t., online lecture)

PD Dr. Christina Brandenberger, Institute of Functional and Applied Anatomy, MHH:
‘Epithelial injury and regeneration in senescence and pulmonary aging’ 


16.02.2022 REBIRTH colloquium (1 pm s.t., online lecture)

PD Dr. Claudia Neunaber, Unfallchirurgie, MHH:
‘Osteochondral allograft transplantation of the knee’


19.01.2022 REBIRTH colloquium (1 pm s.t., online lecture)

Prof. Dr. Renata Stripecke, Klinik für Hämatologie, Hämostase, Onkologie und Stammzelltransplantation, MHH:
‘Rebirth of translational immune oncology for leukemias and lymphomas: from the cell engineering, disease models and GMP towards the patients’


15.12.2021 REBIRTH Kolloquium (1 pm s.t., online und im Hörsaal l R (I6-H0-4050)

Prof. Dr. Andrea Hoffmann, Orthopaedic Clinic, MHH:
‘Innovative biomaterials and the future of mesenchymal ʽstemʼ cells’

Prof. Dr. Günter Höglinger Department of Neurology, MHH:
‘Regeneration in Neurodegenerative Diseases - What is Possible?’


17.11.2021 REBIRTH Kolloquium (1 pm s.t., online und im Hörsaal l R (I6-H0-4050)

Dr. Sarah Strauß, Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, MHH:
‘Preliminary Application of Spider Silk in Rats Spinal Cord’

Dr. Ruth Olmer, LEBAO, MHH:
‘iPS derived respiratory and vascular cell types – towards treatment of lung diseases’


13.10.2021 REBIRTH Kolloquium (1 pm s.t., online und im Hörsaal S (I6-H0-6040)

Anna Rafiei Hashtchin, PhD, Institut für Experimentelle Hämatologie, MHH:
‘Moving iPSC-derived macrophages towards clinical applications’

Allan Ertmann Karlsen, Vizepräsident der Zelltherapieforschung, Novo Nordisk:
‘Novo Nordisk’s ambitions in the field of Cell Therapy’


29.09.2021 - REBIRTH Kolloquium (1 pm s.t., online und im Hörsaal H)

PD Dr. Mark Ph. Kühnel, Institut für Pathologie, Laborleiter der Arbeitsgruppe Lungenforschung, Deutsches Zentrum für Lungenforschung (DZL), MHH:
‘COVID-19 – Regenerative Angiogenesis in Lungs and Hearts’

Prof. Dr. Armin Braun, Division Director Preclinical Pharmacology and Toxicology, Fraunhofer ITEM:
‘Drug repurposing as a novel approach in drug development using the example of inhalative therapy against Covid-19’


14.07.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Prof Dr. Claudia Grothe, Institut für Neuroanatomie und Zellbiologie, MHH:
‘Establishment and validation of an alpha-synuclein parkinson disease rat model – possible protective and replacing therapeutic approaches’

Prof. Dr. Thomas Moritz,Institut für Experimentelle Hämatologie, MHH:
‘Generation of enhanced macrophages for regenerative therapies and beyond’


02.06.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Dr. Andres Hilfiker, LEBAO, MHH:
‘Decellularized heart valve protheses - from the allogeneic to the xenogeneic graft’

James Thackeray, Ph.D., Klinik für Nuklearmedizin, MHH:
‘Imaging Molecular Markers of Cardiac Injury, Repair and Regeneration’


05.05.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Dr. Christian Bär, Institut für Molekulare und Translationale Therapiestrategien (IMTTS), MHH:
‘Telomerase as therapeutic target in cardiovascular disease’

Prof. David Zebrowski, Ph.D., Chinese University of Hong Kong, Faculty of Medicine, Department of Medicine & Therapeutics, the Centre for Cardiovascular Genomics and Medicine, and the Hong Kong Hub of Paediatric Excellence (HK HOPE):
‘Cardiomyocyte terminal differentiation, de-differentiation, and the centrosome’


21.04.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Prof. Dr. Ina Gruh, LEBAO, MHH:
‘Stem cell-derived cardiac cells and tissues for therapy and disease modeling’

Prof. Dr. Alexander Heisterkamp,Institut für Quantenoptik, LUH:
‘Biophotonics - Application of light in cells and tissues’


10.03.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Prof. Dr. Axel Schambach, Institut für Experimentelle Hämatologie, MHH:
‘From stem cell-based modeling to novel therapeutic strategies’

Dr. Robert Zweigerd, LEBAO, MHH:
‘Making and Maintaining Cardiac Progenitors from human Pluripotent Stem Cells’

17.02.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Prof. Dr. Hermann Haller, Klinik für Nieren- und Hochdruckerkrankungen, MHH:
‘Regeneration and Aging - Mount Desert Biological Laboratory’

Prof. Dr. Falk Büttner, Institut für Klinische Biochemie, MHH:
‘Identification and validation of a novel glycan cell surface marker for human pluripotent stem cells’


20.01.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge)

Prof. Dr. Doris Steinemann, Institut für Humangenetik, MHH:
'Repetitive sequences in human genomes and their contribution to disease development'

Prof. Dr. Hildegard Büning, Institut für Experimentelle Hämatologie, MHH:
'Tailoring Adeno-Associated Virus (AAV) Vectors for Gene Therapy'

Scientific afternoon

Scientific afternoons organized by the Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG) take place every two months on Wednesday at 5 p.m.. The usual venue is lecture hall N of the MHH (near the library). The goal of these meetings is to stimulate improved communication between clinicians and research personnel. Reports are presented by members of HTTG, LEBAO, the Lung Transplantation Unit, or foreign guests who have been invited to present their research. There is typically one report on a clinical topic and one report on a research topic.

Past events